Insights on the Vision Care Global Market to 2027 - by Product Type, Distribution Channel and Region
April 21, 2022 08:13 ET
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Graybug Vision Appoints Dirk Sauer to Board of Directors
April 13, 2022 16:05 ET
|
Graybug Vision, Inc.
BALTIMORE, April 13, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
March 30, 2022 07:15 ET
|
Graybug Vision, Inc.
Phase 2 trial with optimized formulation in wet AMD expected to start in fourth quarter of 2022Phase 1 trial in glaucoma expected to commence in first quarter of 2023Acquired corneal gene therapy...
Global Contact Lenses Markets, 2022-2027 - Introduction of Hi-Tech Contact Lenses / Increasing Use of Silicone Hydrogel Contact Lenses / High Consumer Preference for Premium Cosmetic Lenses
March 28, 2022 05:23 ET
|
Research and Markets
Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "Contact Lenses Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The contact lenses market...
iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK
March 28, 2022 02:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK UK patients and surgeons now able to benefit from the only commercially available MIGS device...
Graybug Vision to Host Virtual R&D Day on March 30, 2022
March 21, 2022 16:30 ET
|
Graybug Vision, Inc.
BALTIMORE, March 21, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Global $22+ Billion Ocular Implants (Glaucoma Implants, Intraocular Lens) Markets to 2030: Increasing Focus on the Development of Technologically Advanced Products is Expected to Drive the Market
March 18, 2022 05:03 ET
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Ocular Implants Market Size, Share & Trends Analysis Report by Product (Glaucoma Implants, Intraocular Lens), by Application (Glaucoma Surgery,...
Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments
March 10, 2022 07:30 ET
|
Graybug Vision, Inc.
BALTIMORE, March 10, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of...
Global Bionic Eye Market Research Report 2021 Featuring Nidek, Nano Retina, MetaModa, Pixium Vision, Monash Vision, iBionics & Optobionics
March 10, 2022 04:03 ET
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Global Bionic Eye Market, By Type (Implant v/s External), By Technology (Electronic v/s Mechanical), By End User (Hospitals, Ophthalmic Clinics,...
ONL Therapeutics Appoints Sushanta Mallick as Chief Development Officer
February 09, 2022 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...